- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Elevation Oncology, Inc. (the “Company”) for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Joseph J. Ferra, Jr., Interim Chief Executive Officer and President, and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
Dated: May 15, 2023 | /s/ Joseph J. Ferra, Jr. |
Joseph J. Ferra, Jr. | |
Interim Chief Executive Officer and President, and (Principal Executive Officer and Principal Financial and Accounting Officer) |